RCUS icon

Arcus Biosciences

173 hedge funds and large institutions have $1.33B invested in Arcus Biosciences in 2022 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 64 increasing their positions, 32 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

16% less capital invested

Capital invested by funds: $1.59B → $1.33B (-$259M)

38% less funds holding in top 10

Funds holding in top 10: 85 (-3)

39% less call options, than puts

Call options by funds: $17.6M | Put options by funds: $28.9M

Holders
173
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$17.6M
Puts
$28.9M
Net Calls
Net Calls Change

Top Buyers

1 +$101M
2 +$42.7M
3 +$19.5M
4
Goldman Sachs
Goldman Sachs
New York
+$18.4M
5
FC
Finepoint Capital
Massachusetts
+$13.6M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$645K
102
$627K
103
$575K
104
$546K
105
$537K
106
$524K
107
$485K
108
$479K
109
$467K
110
$450K
111
$449K
112
$448K
113
$441K
114
$399K
115
$388K
116
$348K
117
$344K
118
$339K
119
$329K
120
$307K
121
$301K
122
$300K
123
$293K
124
$255K
125
$251K